These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19933916)

  • 21. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
    Scagliotti GV
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
    Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY
    Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response.
    Gupta A; Srivastava S; Prasad R; Natu SM; Mittal B; Negi MP; Srivastava AN
    Respirology; 2010 Feb; 15(2):349-56. PubMed ID: 20199646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer.
    De Pas T; Raimondi S; Pelosi G; Spaggiari L; De Braud F; Veronesi G; Maisonneuve P
    Acta Oncol; 2010 May; 49(4):480-4. PubMed ID: 20105088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis.
    Lee CY; Park SY; Shin TR; Park YB; Kim CH; Jang SH; Lee JW
    Anticancer Res; 2013 Jun; 33(6):2755-61. PubMed ID: 23749937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
    Douillard JY; Tribodet H; Aubert D; Shepherd FA; Rosell R; Ding K; Veillard AS; Seymour L; Le Chevalier T; Spiro S; Stephens R; Pignon JP;
    J Thorac Oncol; 2010 Feb; 5(2):220-8. PubMed ID: 20027124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
    Feld R; Rubinstein L; Thomas PA
    Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
    Butts CA; Ding K; Seymour L; Twumasi-Ankrah P; Graham B; Gandara D; Johnson DH; Kesler KA; Green M; Vincent M; Cormier Y; Goss G; Findlay B; Johnston M; Tsao MS; Shepherd FA
    J Clin Oncol; 2010 Jan; 28(1):29-34. PubMed ID: 19933915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
    Pignon JP; Tribodet H; Scagliotti GV; Douillard JY; Shepherd FA; Stephens RJ; Dunant A; Torri V; Rosell R; Seymour L; Spiro SG; Rolland E; Fossati R; Aubert D; Ding K; Waller D; Le Chevalier T;
    J Clin Oncol; 2008 Jul; 26(21):3552-9. PubMed ID: 18506026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin-based adjuvant chemotherapy in resected non-small-cell lung cancer.
    Gibson AD
    Clin Lung Cancer; 2003 Jul; 5(1):18-20. PubMed ID: 14596698
    [No Abstract]   [Full Text] [Related]  

  • 38. MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.
    Kamal NS; Soria JC; Mendiboure J; Planchard D; Olaussen KA; Rousseau V; Popper H; Pirker R; Bertrand P; Dunant A; Le Chevalier T; Filipits M; Fouret P;
    Clin Cancer Res; 2010 Feb; 16(4):1206-15. PubMed ID: 20145178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer.
    McCaughan GJ; Blinman PL; Boyer MJ; Stockler MR
    Intern Med J; 2013 Apr; 43(4):424-9. PubMed ID: 22647141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
    Buhl IK; Santoni-Rugiu E; Ravn J; Hansen A; Christensen IJ; Jensen T; Pratt B; Askaa J; Jensen PB; Knudsen S; Sørensen JB
    PLoS One; 2018; 13(3):e0194609. PubMed ID: 29566065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.